Private equity giant KKR is poised to make an additional investment into Australian cancer care provider GenesisCare, which is offering new a precision medicine test for women diagnosed with early-stage breast cancer enabling for better-informed care decisions.
Dan Collins, GenesisCare founder and chief executive, moved to California last year after buying Florida-based 21st Century Oncology, in a $1.6 billion deal, which created a $5 billion combined group.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
